Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

  • This share is currently suspended. It was suspended at a price of 0.75
  • There is currently no data for BELL

Director/PDMR Shareholding

4 Jul 2024 13:30

RNS Number : 2083V
Belluscura PLC
04 July 2024
 

4 July 2024

 

BELLUSCURA PLC

("Belluscura" or the "Company")

 

Director/PDMR Shareholding

 

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that on 3 July 2024, David Poutney, Non-Executive Director of the Company, sold 4,350,000 ordinary shares of 1 penny each ("Ordinary Shares") held in his own name, and 3,800,000 Ordinary Shares were acquired by his self-invested pension plan ("SIPP") with the balance of 550,000 Ordinary Shares being acquired by his wife's, Vivienne Poutney and a person closely associated, SIPP.

Following this transfer, Mr Poutney, and his persons closely associated, remain interested in a total of 14,255,731 Ordinary Shares in the Company, representing 8.53 per cent. of the Company's issued Ordinary Share capital.

 

For further information please contact:

 

Belluscura plc

Tel: +44 (0)20 3128 8100

Adam Reynolds, ChairmanRobert Rauker, Chief Executive Officer

 

 

 

SPARK Advisory Partners Limited

Nominated Adviser

Tel: +44 (0)20 3368 3550

Neil Baldwin / Jade Bayat

 

 

 

Dowgate Capital Limited

Broker

Tel: +44 (0)20 3903 7715

Russell Cook / Nicholas Chambers

 

 

 

MHP Group

Financial PR & Investor Relations

Tel: +44 (0)20 3128 8100

email: Belluscura@mhpgroup.com

Katie Hunt / Matthew Taylor

 

 

About Belluscura plc (https://belluscura.com/)

Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Poutney (PDMR)

2

Reason for notification

a)

Position / status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Belluscura plc

b)

LEI

213800BRJQZE56XBPW94

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.01 each in Belluscura plc

ISIN: GB00BD3B8Z11

b)

Nature of the transaction

(i) Sale of shares

(ii) Purchase of shares in SIPP

c)

Price(s) and volumes(s)

Price(s)

Volumes(s)

(i) Sale: 16p

 

(ii) Purchase: 16p

4,350,000

 

3,800,000

 

 

 

 

 

d)

Aggregated information

n/a

e)

Date of the transaction

3 July 2024

f)

Place of the transaction

London Stock Exchange

 

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Vivienne Poutney

2

Reason for notification

a)

Position / status

Person closely associated of David Poutney

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Belluscura plc

b)

LEI

213800BRJQZE56XBPW94

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.01 each in Belluscura plc

ISIN: GB00BD3B8Z11

b)

Nature of the transaction

Purchase of shares in SIPP

c)

Price(s) and volumes(s)

Price(s)

Volumes(s)

16p

550,000

 

 

 

 

 

d)

Aggregated information

n/a

e)

Date of the transaction

3 July 2024

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHRIMTTMTTMBII
Date   Source Headline
13th Jan 202211:05 amRNSSecond Price Monitoring Extn
13th Jan 202211:00 amRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSExercise of Warrants and Total Voting Rights
29th Nov 20217:01 amRNSReimbursement approvals
29th Nov 20217:00 amRNSExercise of Warrants and Total Voting Rights
4th Nov 20217:00 amRNSTrading update
1st Nov 20217:00 amRNSThe Pulse: Healthcare Innovation Breakfast
25th Oct 20217:00 amRNSProduct wins Top Award at US Trade show
18th Oct 20217:00 amRNSNew US Distribution Agreement
8th Oct 20217:00 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSNotice of Results
31st Aug 20217:00 amRNSBelluscura supports rationale for wider oxygen use
27th Jul 20217:00 amRNSManufacturing and Distribution Agreement
13th Jul 20217:00 amRNSThird US Distribution Agreement
8th Jul 20217:00 amRNSThe US Centers for Medicare & Medicaid Services
5th Jul 20217:00 amRNSSecond US Distribution Agreement
30th Jun 202112:29 pmRNSResult of AGM
24th Jun 20211:13 pmRNSHolding(s) in Company
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20212:05 pmRNSSecond Price Monitoring Extn
23rd Jun 20212:00 pmRNSPrice Monitoring Extension
23rd Jun 20217:00 amRNSFirst US Distribution Agreement
15th Jun 20217:00 amRNSSenior Management Appointment
9th Jun 20214:15 pmRNSExercise of Warrants
2nd Jun 20217:00 amRNSHolding(s) in Company
28th May 20217:00 amRNSAdmission to trading on AIM; First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.